Scientists probe Heart's electrical secrets to perfect pacing

NCT ID NCT06540521

Recruiting now Knowledge-focused Sponsor: Medtronic Cardiac Rhythm and Heart Failure Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at the electrical signals in the heart during a special type of pacing called left bundle branch area pacing (LBBAP), used in people with heart failure or slow heart rates. Researchers will measure these signals at different pacing strengths and body positions in 75 adults who already have a pacemaker. The goal is to gather data that could help create a smarter algorithm to automatically detect when the pacing is working correctly, potentially improving therapy without extra procedures.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a smarter algorithm that automatically adjusts heart pacing, making therapy more effective and personalized for patients.
What could go wrong: This is an observational study with only 75 participants, so results may not apply to everyone. It is designed to gather data, not to test a new treatment, so direct patient benefits are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRADYCARDIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Bradycardia heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRADYCARDIA HEART FAILURE

Contacts and locations

Locations

Shanghai Chest Hospital
RECRUITING

Shanghai, Shanghai Municipality, China
Zhejiang Greentown Cardiovascular Hospital
NOT_YET_RECRUITING

Hangzhou, Zhejiang, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.